Prices delayed by at least 15 minutes | Print
Hanetf Icav HARBOR HEALTH CARE UCITS ETF ACC USD (WELL)
Open
$7.514
Previous close
$7.5315
Trade high
$7.546
Income frequency
-
Year low
$6.25
Year high
$8.447
Replication method
NOT Applicable
Volume
19,486
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.89
ISIN
IE00BJQTJ848
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Before investing please read:
Share price
Asset allocation
Top 10 holdings
| Holdings 23/04/2026 | % of assets |
|---|---|
| ASCENDIS PHARMA A/S | 9.02 |
| Eli Lilly and Co | 8.68 |
| Legend Biotech Corp ADR | 5.94 |
| Vaxcyte Inc Ordinary Shares | 5.77 |
| Insmed Inc | 4.97 |
| Intuitive Surgical Inc | 4.96 |
| Rhythm Pharmaceuticals Inc | 4.82 |
| Abivax SA ADR | 4.67 |
| AbbVie Inc | 4.53 |
| Natera Inc | 3.79 |
Investment objective
The Sub-Fund is actively managed and in order to seek to achieve its investment objective the Sub-Fund invests primarily in equity securities, principally common and preferred stocks and equity related securities of companies of any market capitalization.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.
Asset class
ETFMorningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.